Itoki Corporation
Itoki Corporation (7972.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Itoki Corporation (7972.T), covering cash flow, earnings, and balance sheets.
Itoki Corporation (7972.T) Income Statement & Financial Overview
Explore comprehensive income reports for Itoki Corporation 7972.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $36.34B | $29.61B | $31.59B | $40.92B |
| Cost of Revenue | $21.18B | $17.64B | $19.89B | $24.55B |
| Gross Profit | $15.15B | $11.97B | $11.70B | $16.37B |
| Gross Profit Ratio | $0.42 | $0.40 | $0.37 | $0.40 |
| R&D Expenses | $2.51B | $0.00 | $686.00M | $607.00M |
| SG&A Expenses | $12.88B | $11.03B | $10.19B | $9.73B |
| Operating Expenses | $12.88B | $11.03B | $10.88B | $10.33B |
| Total Costs & Expenses | $34.07B | $28.67B | $30.77B | $34.88B |
| Interest Income | $0.00 | $3.00M | $7.00M | $2.00M |
| Interest Expense | $0.00 | $79.00M | $86.00M | $51.00M |
| Depreciation & Amortization | $776.75M | $744.00M | $756.00M | $713.00M |
| EBITDA | $3.05B | $1.86B | $1.41B | $6.06B |
| EBITDA Ratio | $0.08 | $0.06 | $0.04 | $0.15 |
| Operating Income | $2.27B | $940.00M | $826.00M | $6.04B |
| Operating Income Ratio | $0.06 | $0.03 | $0.03 | $0.15 |
| Other Income/Expenses (Net) | -$569.00M | $95.00M | $501.00M | -$33.00M |
| Income Before Tax | $1.70B | $1.03B | $1.33B | $6.006B |
| Income Before Tax Ratio | $0.05 | $0.03 | $0.04 | $0.15 |
| Income Tax Expense | $294.00M | $309.00M | $344.00M | $1.90B |
| Net Income | $1.38B | $714.00M | $985.00M | $4.10B |
| Net Income Ratio | $0.04 | $0.02 | $0.03 | $0.10 |
| EPS | $28.11 | $14.51 | $20.02 | $85.71 |
| Diluted EPS | $28.11 | $14.51 | $20.02 | $85.71 |
| Weighted Avg Shares Outstanding | $49.20M | $49.21M | $49.20M | $47.85M |
| Weighted Avg Shares Outstanding (Diluted) | $49.20M | $49.20M | $49.20M | $47.85M |
Over the past four quarters, Itoki Corporation demonstrated steady revenue growth, increasing from $40.92B in Q1 2024 to $36.34B in Q4 2024. Operating income reached $2.27B in Q4 2024, maintaining a consistent 6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $3.05B, reflecting operational efficiency. Net income rose to $1.38B, with EPS at $28.11. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan